கார்டினல் ஆரோக்கியம் சிறப்பு தீர்வுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கார்டினல் ஆரோக்கியம் சிறப்பு தீர்வுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கார்டினல் ஆரோக்கியம் சிறப்பு தீர்வுகள் Today - Breaking & Trending Today

Cardinal Health reports third-quarter results for fiscal year 2021


Share this article
Share this article
DUBLIN, Ohio, May 6, 2021 /PRNewswire/  Cardinal Health (NYSE: CAH) today reported third-quarter fiscal year 2021 revenue of $39.3 billion, in-line with the third quarter of last year. Third-quarter GAAP operating earnings decreased 16% to $473 million, primarily due to the write-down of the net assets held for sale from the planned divestiture of the Cordis business. Third-quarter GAAP diluted earnings per share (EPS) decreased to $0.40, due to the previously-disclosed tax effect of the litigation charge in the first quarter.
Non-GAAP operating earnings decreased 4% to $689 million in the quarter due to the negative impact from COVID-19, primarily concentrated in the Pharmaceutical segment. Non-GAAP diluted EPS decreased 6% to $1.53 in the quarter, reflecting a higher non-GAAP effective tax rate, partially offset by lower interest expense. ....

United States , Sarah Shew , Hellman Friedman , Mike Kaufmann , Kevin Moran , Specialty Solutions , Us Department Of Health , Human Services , Cardinal Health Form , Cardinal Health Board Of Directors , Tech Solutions , Cardinal Health , Cardinal Health Specialty Solutions , Strategic National Stockpile , Cardinal Health Inc , Pharmaceutical Distribution , Health Board , Health Specialty Solutions , America Healthcare Conference , Investor Relations , Consolidated Statements , Coronavirus Aid , Economic Security , Cash Flows , ஒன்றுபட்டது மாநிலங்களில் , சாரா காட்டு ,

New Manuscript Examines FDA's Use OF RWE In Drug Approvals


New Manuscript Examines FDA s Use OF RWE In Drug Approvals
By Ed Miseta, Chief Editor, Clinical Leader
Follow Me On Twitter @EdClinical
The FDA review process for new drugs has transformed over recent years, resulting in faster and more efficient approvals. One aspect of that transformation is the use of real-world evidence (RWE) to complement clinical-trial evidence. The introduction of the 21
st Century Cures Act in 2016 has increased interest in the potential use of RWE in new drug approvals, but little has been shared on how the FDA is 
actually using RWE in their reviews.
Value in Health and hopes to share insights on that FDA process. The manuscript reviews five recent examples where RWE was submitted in support of the FDA approvals of original or supplementary indications for oncology drugs. The study found that, by bridging the gap between the constraints of the clinical trial setting and the realities of clinical practice, RWE can add value to ....

Ed Miseta , Bruce Feinberg , Cardinal Health Speciality Solutions , Cardinal Health , Chief Editor , Century Cures Act , Real World Evidence , காயங்கள் ஃபைன்பெர்க் , கார்டினல் ஆரோக்கியம் சிறப்பு தீர்வுகள் , கார்டினல் ஆரோக்கியம் , தலைமை ஆசிரியர் , சிஇஎன்டியுவ்ஆர்ஒய் குணப்படுத்துகிறது நாடகம் , ரியல் உலகம் ஆதாரம் ,